Cognitive dysfunctions in patients with schizophrenia disorders are common, have
prognostic value, informs treatment planning and rehabilitation, and provide a basis for …

Objective: To illustrate and quantify how using different normative systems influences the
accuracy of identifying cognitive impairment in people with schizophrenia spectrum …

Objective To create clinical normative data tables for Norwegian patients with schizophrenia
spectrum disorders, to examine whether clinical normative data from Norway differs from …

Objective: We examined the frequency of possible invalid test scores on the Repeatable
Battery for the Assessment of Neuropsychological Status (RBANS) in patients with …

Background Impairment in a wide range of cognitive abilities has been consistently reported
in individuals with schizophrenia. Both neurocognitive and social cognitive deficits are …

Background: The Repeatable Battery for the Assessment of Neuropsychological Status
(RBANS) is a brief, standardized cognitive screening instrument that assesses several …

Approximately one-in-five individuals with psychotic disorders (ie, schizophrenia spectrum
disorders [SSD]) fail performance validity indicators (PVIs) during neurocognitive testing …

The aim of this study was to identify the best subset of neuropsychological tests for
prediction of several different aspects of functioning in a large (n= 236) sample of older …

Cognitive impairment has been identified in the early phase of schizophrenia spectrum
disorders, and is a major contributor to disease-related disability. While screening tools …

Introduction: Cognitive impairment is a relatively frequent aspect of schizophrenia and it
impedes psychosocial performance and ability to reintegrate into society. Problem …